Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R1507 plus Letrozole in advanced breast cancer
NCT00796107Phase 2Terminated
- Sponsor
- Roche
- Start
- Jan 2009
- Primary completion
- Mar 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of teprotumumab in breast cancer, sponsored by Roche. Started Jan 2009; status: terminated.
02
Drugs
teprotumumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00796107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00796107.